» Articles » PMID: 27598147

Advances in Integrating Traditional and Omic Biomarkers When Analyzing the Effects of the Mediterranean Diet Intervention in Cardiovascular Prevention

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2016 Sep 7
PMID 27598147
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Intervention with Mediterranean diet (MedDiet) has provided a high level of evidence in primary prevention of cardiovascular events. Besides enhancing protection from classical risk factors, an improvement has also been described in a number of non-classical ones. Benefits have been reported on biomarkers of oxidation, inflammation, cellular adhesion, adipokine production, and pro-thrombotic state. Although the benefits of the MedDiet have been attributed to its richness in antioxidants, the mechanisms by which it exercises its beneficial effects are not well known. It is thought that the integration of omics including genomics, transcriptomics, epigenomics, and metabolomics, into studies analyzing nutrition and cardiovascular diseases will provide new clues regarding these mechanisms. However, omics integration is still in its infancy. Currently, some single-omics analyses have provided valuable data, mostly in the field of genomics. Thus, several gene-diet interactions in determining both intermediate (plasma lipids, etc.) and final cardiovascular phenotypes (stroke, myocardial infarction, etc.) have been reported. However, few studies have analyzed changes in gene expression and, moreover very few have focused on epigenomic or metabolomic biomarkers related to the MedDiet. Nevertheless, these preliminary results can help to better understand the inter-individual differences in cardiovascular risk and dietary response for further applications in personalized nutrition.

Citing Articles

Foodomics: A sustainable approach for the specific nutrition and diets for human health.

Mahato D, Kamle M, Pandhi S, Pandey S, Gupta A, Paul V Food Chem X. 2024; 24:101872.

PMID: 39483356 PMC: 11525469. DOI: 10.1016/j.fochx.2024.101872.


Non-targeted LC-MS/MS metabolomic profiling of human plasma uncovers a novel Mediterranean diet biomarker panel.

Macias S, Yilmaz A, Kirma J, Moore S, Woodside J, Graham S Metabolomics. 2023; 20(1):3.

PMID: 38066384 PMC: 10709258. DOI: 10.1007/s11306-023-02058-y.


Biomarkers of Micronutrients and Phytonutrients and Their Application in Epidemiological Studies.

Zheng J, Wu F, Wang F, Cheng J, Zou H, Li Y Nutrients. 2023; 15(4).

PMID: 36839326 PMC: 9959711. DOI: 10.3390/nu15040970.


Modern vision of the Mediterranean diet.

Kiani A, Medori M, Bonetti G, Aquilanti B, Velluti V, Matera G J Prev Med Hyg. 2022; 63(2 Suppl 3):E36-E43.

PMID: 36479477 PMC: 9710405. DOI: 10.15167/2421-4248/jpmh2022.63.2S3.2745.


Mediterranean Diet and Genetic Determinants of Obesity and Metabolic Syndrome in European Children and Adolescents.

Seral-Cortes M, Larruy-Garcia A, De Miguel-Etayo P, Labayen I, Moreno L Genes (Basel). 2022; 13(3).

PMID: 35327974 PMC: 8954235. DOI: 10.3390/genes13030420.


References
1.
Choi H, Lee D, Jeon H, Kim D, Lee Y, Oh T . Transcription factor 7-like 2 (TCF7L2) gene polymorphism rs7903146 is associated with stroke in type 2 diabetes patients with long disease duration. Diabetes Res Clin Pract. 2014; 103(3):e3-6. DOI: 10.1016/j.diabres.2013.12.051. View

2.
Fito M, Guxens M, Corella D, Saez G, Estruch R, de la Torre R . Effect of a traditional Mediterranean diet on lipoprotein oxidation: a randomized controlled trial. Arch Intern Med. 2007; 167(11):1195-1203. DOI: 10.1001/archinte.167.11.1195. View

3.
Di Daniele N, Di Renzo L, Noce A, Iacopino L, Ferraro P, Rizzo M . Effects of Italian Mediterranean organic diet vs. low-protein diet in nephropathic patients according to MTHFR genotypes. J Nephrol. 2014; 27(5):529-36. DOI: 10.1007/s40620-014-0067-y. View

4.
Corella D, Sorli J, Estruch R, Coltell O, Ortega-Azorin C, Portoles O . MicroRNA-410 regulated lipoprotein lipase variant rs13702 is associated with stroke incidence and modulated by diet in the randomized controlled PREDIMED trial. Am J Clin Nutr. 2014; 100(2):719-31. DOI: 10.3945/ajcn.113.076992. View

5.
Ruiz-Canela M, Toledo E, Clish C, Hruby A, Liang L, Salas-Salvado J . Plasma Branched-Chain Amino Acids and Incident Cardiovascular Disease in the PREDIMED Trial. Clin Chem. 2016; 62(4):582-92. PMC: 4896732. DOI: 10.1373/clinchem.2015.251710. View